Open AccessDietary Reference Intakes based on chronic disease endpoints: outcomes from a case study workshop for omega 3’s EPA and DHA
Author(s) -
Megan Racey,
Amanda J. MacFarlane,
Susan E. Carlson,
Ken D. Stark,
M Plourde,
Catherine J. Field,
Allison A. Yates,
George A. Wells,
Andrea Grantham,
Richard P. Bazinet,
David W.L.
Publication year - 2021
Publication title -
applied physiology, nutrition and metabolism/applied physiology, nutrition, and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.789
H-Index - 89
eISSN - 1715-5320
pISSN - 1715-5312
DOI - 10.1139/apnm-2020-0994
Subject(s) - dietary reference intake , medicine , novelty , chronic disease , disease , environmental health , gerontology , intensive care medicine , psychology , biology , social psychology , ecology , nutrient
Given the focus on developing Dietary Reference Intakes (DRIs) based on chronic disease risk reduction and recent research for omega-3 long chain PUFA since the last DRI review, the Canadian Nutrition Society convened a panel of stakeholders for a 1-day workshop in late 2019. Attendees discussed the new NASEM guidelines for establishing DRI values based on chronic disease risk endpoints and the strength of current evidence for EPA and DHA as it relates to the new guidelines. Novelty: Summarizes evidence and expert opinions regarding the potential for reviewing DRI values for EPA and DHA and cardiovascular disease risk and early development.